Accelerating adoption of group information sessions for menopause in the United Kingdom

Accelerating the adoption of group clinics in the United Kingdom

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

ISRCTN

Registry ID

ISRCTN51562508

Enrollment

3939

Registered

2024-03-21

Start date

2024-03-22

Completion date

Unknown

Last updated

2024-04-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Impartation of knowledge about menopause symptoms and options available to manage menopause Not Applicable

Interventions

1. Control arm: Respondents receive a standard text message invitation to attend a group clinic. 2. Treatment arm 1 (peer group information): Respondents receive a standard text message invitation pl

Eligibility

Sex/Gender

Female

Inclusion criteria

Inclusion criteria: 1. Should not have participated in the pretest survey for this project 2. Female 3. Aged 45-60 years

Exclusion criteria

Exclusion criteria: 1. Participated in the pretest survey for this project 2. Not female 3. Aged under 45 or over 60 years

Design outcomes

Primary

Measure	Time frame
1. Selection of a group clinic, a one-on-one, or neither, measured using 0-1 survey responses in Survey 1 at baseline 2. Extent of decisional conflict experienced in selecting, measured using 0-1 survey responses in Survey 1 at baseline 3. Attendance of a one-on-one appointment or a group clinic measured using a 0-1 variable by implementation partner ELC works during the 10-week intervention period between baseline and endline	—

Measure

Time frame

1. Selection of a group clinic, a one-on-one, or neither, measured using 0-1 survey responses in Survey 1 at baseline 2. Extent of decisional conflict experienced in selecting, measured using 0-1 survey responses in Survey 1 at baseline 3. Attendance of a one-on-one appointment or a group clinic measured using a 0-1 variable by implementation partner ELC works during the 10-week intervention period between baseline and endline

—

Secondary

Measure	Time frame
1. Duration of each appointment measured using a watch by implementation partner ELC works 2. Time spent by the menopause expert in each appointment, measured using a watch by ELC Works during the 10-week intervention period between baseline and endline 3. Satisfaction with the appointment, measured using 1-7 Likert Scale variables in online Survey 2 at endline 4. Knowledge of menopause symptoms measured using 0-1 variables in online Surveys 1 and 2 at baseline and endline 5. Knowledge of menopause management options measured using 0-1 variables in online Surveys 1 and 2 at baseline and endline 6. Channels through which respondents obtain information about menopause measured using 0-1 variables in online Surveys 1 and 2 at baseline and endline 7. Demographic variables measured using survey responses in online Survey 1 at baseline 8. Life stage (pre-menopause, menopause, post-menopause) measured using survey responses in online Survey 1 at baseline 9. Severity of menopause symptoms measured using 0-3 Likert scale variables in Survey 1 at baseline 10. The number of patients in each group clinic appointment measured by counting by ELC Works during the 10-week intervention period between baseline and endline	—

Measure

Time frame

1. Duration of each appointment measured using a watch by implementation partner ELC works 2. Time spent by the menopause expert in each appointment, measured using a watch by ELC Works during the 10-week intervention period between baseline and endline 3. Satisfaction with the appointment, measured using 1-7 Likert Scale variables in online Survey 2 at endline 4. Knowledge of menopause symptoms measured using 0-1 variables in online Surveys 1 and 2 at baseline and endline 5. Knowledge of menopause management options measured using 0-1 variables in online Surveys 1 and 2 at baseline and endline 6. Channels through which respondents obtain information about menopause measured using 0-1 variables in online Surveys 1 and 2 at baseline and endline 7. Demographic variables measured using survey responses in online Survey 1 at baseline 8. Life stage (pre-menopause, menopause, post-menopause) measured using survey responses in online Survey 1 at baseline 9. Severity of menopause symptoms measured using 0-3 Likert scale variables in Survey 1 at baseline 10. The number of patients in each group clinic appointment measured by counting by ELC Works during the 10-week intervention period between baseline and endline

—

Countries

England, United Kingdom

Contacts

Public ContactKamalini Ramdas

kramdas@london.edu+44 (0)7966908820

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026